VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $111,000 | +20.7% | 4,525 | 0.0% | 0.00% | – |
| Q2 2016 | $92,000 | -95.6% | 4,525 | -94.3% | 0.00% | -100.0% |
| Q1 2016 | $2,104,000 | -84.5% | 80,000 | -40.0% | 0.00% | -85.7% |
| Q4 2015 | $13,561,000 | -94.2% | 133,405 | -89.8% | 0.01% | -94.4% |
| Q3 2015 | $233,784,000 | -32.2% | 1,310,597 | -15.6% | 0.25% | -30.1% |
| Q2 2015 | $344,854,000 | +27.2% | 1,552,350 | +13.7% | 0.36% | +29.1% |
| Q1 2015 | $271,188,000 | -2.3% | 1,365,358 | -29.6% | 0.28% | -0.4% |
| Q4 2014 | $277,636,000 | -3.7% | 1,940,019 | -11.7% | 0.28% | -2.8% |
| Q3 2014 | $288,347,000 | +31.6% | 2,197,763 | +26.5% | 0.29% | +38.6% |
| Q2 2014 | $219,181,000 | -12.1% | 1,737,877 | -8.1% | 0.21% | -15.2% |
| Q1 2014 | $249,378,000 | +7.4% | 1,891,662 | -4.4% | 0.24% | +9.4% |
| Q4 2013 | $232,273,000 | +5.7% | 1,978,482 | -6.1% | 0.22% | +0.9% |
| Q3 2013 | $219,719,000 | +34.1% | 2,105,992 | +10.7% | 0.22% | +28.5% |
| Q2 2013 | $163,818,000 | – | 1,903,094 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |